Table 2_Autologous regenerative cell therapy for female stress urinary incontinence: a sys

A meta-analysis of 19 clinical studies involving 591 patients evaluating autologous regenerative cell therapy for female stress urinary incontinence. The analysis, conducted by Jiemei Chen, reports pooled cure and improvement rates and assesses secondary outcomes including pad tests and quality of life scores. The dataset was last updated on June 3, 2026.

Use Cases

• Benchmarking clinical outcomes for regenerative cell therapies based on reported cure and improvement rates.
• Analyzing heterogeneity in treatment effects across studies based on the significant heterogeneity noted in the results.
• Assessing the safety profile of a medical intervention based on the reported adverse event and loss to follow-up rates.
• Evaluating publication bias in medical research based on the funnel plot, Begg test, and Egger test results mentioned.

Strengths

• Includes data from 19 studies and 591 patients, providing a consolidated view of the field.
• Reports specific pooled outcome rates: a 41% cure rate and a 55% improvement rate from 17 studies.
• Assesses multiple secondary outcomes including pad tests, leakage frequency, questionnaire scores, and urodynamic parameters.

Limitations

• Description metadata is limited; actual data quality requires manual inspection after download.
• Column-level documentation is absent; field semantics must be inferred after download.
• The authors note significant heterogeneity across all outcome measures and low-to-moderate study quality in the included trials.

Provenance

Source

figshare

Collection Method

Systematic review and meta-analysis of published clinical studies from databases including PubMed, Web of Science, EMBASE, Cochrane Library, and CINAHL.

Freshness

Last updated 2026-06-03 04:47:21; freshness should be verified.